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Male sex has emerged as a major independent risk factor for severe disease and death from severe acute respiratory syndrome coronavirus–related coronavirus disease 2019 (COVID-19).1 Severe acute respiratory syndrome 
coronavirus 2 infects cells via the angiotensin converting enzyme 2 (ACE2) recep-
tor, a widely distributed cell-surface receptor.2 In 2 cohorts of patients with heart 
failure (BIOSTAT-CHF [Biology Study to Tailored Treatment in Chronic Heart Fail-
ure]), we recently showed that age-adjusted plasma concentrations of ACE2 are 
higher in men than in women.3
To explore whether there are sex-specific genotype effects on plasma ACE2 
concentrations, we undertook sex-specific and combined genome-wide associa-
tions studies of plasma ACE2, measured using the Olink platform (which provides 
results expressed in the form of relative quantification without units), in the com-
bined index and validation cohorts of BIOSTAT-CHF (2420 men and 1022 women, 
mean age 70.9±11.6 years).3 The BIOSTAT-CHF study was approved by institution-
al review boards at participating centers. Further details on the cohorts are avail-
able in Sama et al.3 Mean plasma ACE2 concentrations were 5.41 (SD 0.74) in 
men and 5.13 (0.75) in women (P=2.6×10–26). Genotyping was performed using 
the Affymetrix Axiom Genome-Wide UKB WCSG Genotyping Array and variants 
imputed to 1000G Phase 1 v3. Further details on imputation and quality control 
are available on request. We tested variants with a minor allele frequency >1% 
and an imputation quality score >0.5 and adjusted the analyses for BIOSTAT-CHF 
cohort, age, and the first 5 principal components.
We identified 3 loci associated with plasma ACE2 concentrations at genome-
wide significance in men, but none in women (Figure A). No additional genome-
wide significance loci were identified in the combined analysis.
The strongest association was with an X-chromosome locus (lead single-nucle-
otide polymorphism rs12551879, minor allele frequency 27.2%, beta 0.13±0.02, 
P=5.93×10–15), which includes the ACE2 gene (Figure B). The strongest association 
in women was rs4646131 (P=1.58×10–3) with a R2=0.16 and D′=0.86 with the lead 
single-nucleotide polymorphism in men (Figure B). The lead variant (rs71076692, 
minor allele frequency 48.4%, beta 0.14±0.02, P=1.49×10–9) at the second locus 
in men on chromosome 12 (Figure C) is an insertion-deletion (indel) variant located 
proximate to HNF1α that encodes a transcription factor known to regulate ACE2 
expression.4 The lead variant (chr21:39834295, minor allele frequency 24.8%, 
beta 0.13±0.03, P=2.87×10–9) at the third locus in men on chromosome 21 (Fig-
ure D) is also an indel located within the ERG gene which encodes a transcription 
factor involved in vascular development and remodeling. Fusion of ERG with the 
nearby gene TMPRSS2, encoding a transmembrane serine protease involved in 
ACE2 cleavage and entry of severe acute respiratory syndrome coronavirus 2 into 
the cell, is a frequent event in prostate cancer.2,5
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A sex interaction analysis showed a significant inter-
action for the third locus on chromosome 21 (P=0.001) 
but not for the loci on chromosomes X (P=0.25) or 12 
(P=0.15). Because of the smaller sample size in women, 
we estimated the power to detect the effects seen in 
men. The power to detect the smallest effect size seen 
in men (chromosome 21) was 53.9% at 5×10–8 and 
93.5% at 5×10–5. The 3 loci explained 4.91% of varia-
tion in plasma ACE2 concentration in men and 1.14% 
in women. The associations were independent of other 
clinical or demographic factors or medication.
The lack of association signals in women at the 3 
identified loci may reflect smaller sample size and lower 
power; however, the >4-fold difference in variation in 
ACE2 concentration explained by these loci between 
men and women supports an hypothesized sex-specific 
genotype effect on plasma ACE2 concentration. The 
association of X-chromosome variants is probably me-
diated by cis-effects on ACE2 transcription. Although 
there are strong candidate genes that may explain 
the associations at the other 2 loci (see earlier), causal 
genes underlying genome-wide association study loci 
are often neither the nearest nor the strongest puta-
tive candidate genes and further investigation of their 
involvement is necessary.
Plasma ACE2 arises from shedding of the receptor 
from cells through the effect of several enzymes includ-
ing TMPRSS2 and ADAM17.2 Any association between 
ACE2 levels and severity of COVID-19 and the extent 
to which plasma ACE2 concentration correlates with 
expression in tissues are both unclear. The genotype ef-
fects observed for plasma ACE2 concentration could re-
flect a similar effect on tissue expression or on receptor 
shredding, at least in some sites. In turn, this could pos-
sibly influence susceptibility to the severity of infection 
by severe acute respiratory syndrome coronavirus 2.
Our analyses were performed in relatively elderly sub-
jects of primarily European Caucasian ancestry with heart 
Figure. Association of genetic variants with plasma ACE2 concentration.
A, Miami plot showing genome-wide association analysis of genetic variants with plasma ACE2 concentration. Chromosomal location of the variants is shown 
on the x axis and –log10 (P value) of the association on the y axis for men (blue, Upper) and women (red, Lower). Dashed reference line shows the genome-wide 
significance threshold of P=5×10–8. B through D, Regional plots showing association with plasma ACE2 concentration of genetic variants on the X-chromosome 
(chrX) around the ACE2 gene (B), on chromosome 12 (chr12) around the HNF1α gene (C), and on chromosome 21 (chr21) around the ERG gene (D). Each 
plot shows associations for men in the upper half and women in the lower half. The top signals for chromosome 12 (rs71076692) and for chromosome 21 
(chr21:39834295) are both indels. Therefore, proxy single-nucleotide polymorphisms (rs7139079 and rs2186346, respectively) in high-linkage disequilibrium with 
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failure.3 These results require replication in other cohorts. 
As suitable cohorts collected during the COVID-19 pan-
demic become available, our findings provide an oppor-
tunity to determine whether these genetic markers asso-
ciated with ACE2 concentrations in BIOSTAT-CHF are also 
associated with differences in outcomes from COVID-19, 
especially in men. If this is the case, genotyping may help 
inform future personalized prevention strategies against 
COVID-19. More broadly, a primarily protective role for 
ACE2 has been proposed in several cardiovascular dis-
eases, and our findings provide new genetic instruments 
to investigate its precise involvement.
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